You are here

  • Home
  • Archive
  • Volume 23, Issue Suppl 1
  • CP-151 Efficacy of 4, 12 and 24 weeks of treatment with ledipasvir/sofosbuvir, simeprevir, sofosbuvir, sofosbuvir/simeprevir and sofosbuvir/daclatasvir in patients with chronic hepatitis C virus

Article metrics

Article menu
Download PDFPDF
Clinical pharmacy
CP-151 Efficacy of 4, 12 and 24 weeks of treatment with ledipasvir/sofosbuvir, simeprevir, sofosbuvir, sofosbuvir/simeprevir and sofosbuvir/daclatasvir in patients with chronic hepatitis C virus

 

Online download statistics by month:

Online download statistics by month: February 2016 to August 2024

AbstractFullPdf
Feb 2016300
Mar 2016100
Apr 2016203
May 2016001
Jun 2016300
Jul 2016102
Aug 2016400
Sep 2016100
Oct 2016200
Nov 2016500
Dec 2016800
Jan 2017300
Feb 20172300
Mar 20171701
Apr 2017400
May 2017500
Jun 2017800
Jul 2017800
Aug 20173000
Sep 20171200
Oct 20176402
Nov 20171401
Dec 2017600
Jan 20182400
Feb 2018700
Mar 20182200
Apr 20181200
May 20181000
Jun 20181600
Jul 20181000
Aug 2018600
Sep 20181200
Oct 2018800
Nov 2018800
Dec 2018800
Jan 2019600
Feb 2019800
Mar 2019400
Apr 2019401
May 2019200
Jun 20191100
Jul 20191200
Sep 2019600
Oct 20192000
Nov 20191200
Dec 20192000
Jan 20201200
Feb 20202200
Mar 20201800
Apr 2020600
May 2020600
Jun 2020600
Jul 2020600
Aug 2020400
Sep 20201400
Oct 20201001
Nov 2020200
Dec 2020600
Jan 20211000
Feb 2021402
Mar 2021600
Apr 2021600
Jul 2021100
Oct 20211400
Nov 20211200
Dec 20211800
Jan 20221200
Feb 2022800
Mar 20221200
Apr 2022800
May 20221200
Jun 2022400
Jul 20221000
Aug 20221000
Sep 2022601
Oct 2022400
Nov 20221000
Dec 2022800
Jan 2023200
Feb 20231000
Mar 20232200
Apr 2023800
May 20231000
Jun 20231600
Jul 2023200
Aug 2023400
Sep 20232000
Oct 20232400
Nov 20232400
Dec 20234600
Jan 20241800
Feb 20242600
Mar 20243800
Apr 20241000
May 2024400
Jun 2024400
Jul 2024601
Aug 2024400
Total1057016